Yellow mercuric oxide ointment and mercury intoxication

Area of Science:

• Toxicology
• Pediatrics
• Dermatology

Background:

• Eczema management in infants often involves topical treatments.
• Yellow mercuric oxide has historical uses in treating skin conditions.

Observation:

• A 4-month-old infant received repeated cutaneous application of yellow mercuric oxide ointment for infected eczema.
• The infant presented with symptoms indicative of systemic toxicity.

Findings:

• Significant mercury poisoning was diagnosed in the infant.
• Toxic levels of mercury were confirmed in the infant's blood, urine, cerebrospinal fluid, and tissue samples.
• This highlights the potential for systemic absorption and toxicity from topical mercury compounds.

Implications:

• Neonatal and pediatric exposure to mercury-containing topical agents requires careful consideration.
• Clinicians should be aware of the risks associated with yellow mercuric oxide in infant dermatological care.
• Alternative, safer treatments for infant eczema should be prioritized to prevent iatrogenic mercury poisoning.